📌 Key Takeaways
- Topic: Silica Supplier Russia: Market Overview and Sourcing Considerations
- Keywords: silica free sample
- Published: 2026-11-20 04:49:13
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica Sand for Glass: Iron Content, Grades and Specifications
- Semiconductor Grade Silica: Purity Standards, Key Specs and Typical Uses
- 62. Wang H., Chen L., Li R., Lv C., Xu Y., Xiong Y. Polydopamine-coated mesoporous silica nanoparticles co-loaded with Ziyuglycoside I and Oseltamivir for synergistic treatment of viral pneumonia. Int. J. Pharm. 2023;645:123412. doi: 10.1016/j.ijpharm.2023.123412. [ DOI ] [ PubMed ] [ Google Scholar ]
- Syloid Silica: Matting, Excipient and Food Grades Explained, with Alternatives
- Silicon Dioxide Structure: Tetrahedral Network and Crystal Forms Explained
- Silica Supplier Mexico: Sourcing Options, Producers and Import Tips
- One of the biggest challenges of tableting greatly potent APIs (antibiotics, hormones, cytostatic molecules) is to attain content uniformity [ 95, 96 ]. Since these molecules are used in small doses, it is demanding to attain a homogeneous powder mixture during mixing and to make sure this homogeneity until the end of tableting. Also, it is a hurdle to develop a reproducible method that ensures content uniformity for each production batch, since the specified dose must be made sure between batches, not just within one batch [ 95, 96 ]. A reliable alternative method is to use mesoporous silica as a carrier system rather than simple powder mixing, thus preventing the segregation and aggregation of the low-dose API during mixing and compression. In this case, the preloaded mesoporous carrier and the necessary excipients are mixed, and then the powder mixture can be compressed directly or after granulation. The drug loading can be controlled by the concentration of the drug solution used to fill the carrier systems, which affects the amount of the drug content in the concluding medicine [ 95, 96 ]. Based on this, nearly unlimitedly low doses can be formulated into tablets, even in a concentration of 0.01%, just by properly preparing the solution [ 96 ]. The technique is well-controllable and dependable, since each tablet has the same drug content and the desired content uniformity. Furthermore, the method can be used in both batch-based and continuous production [ 96 ]. This may be a promising finding because there is evidence that it is challenging to move from batch-based to continuous manufacturing while maintaining the desired drug content and content uniformity [ 94 ]. But it should be noted that in this study, no nanocarrier system was used [ 94 ], so utilizing MSN formulations could make an enormous improvement in developing continuous tablet manufacturing [ 96 ]. A study shown that MSN carriers can also be used in orodispersible films to enhance the dissolution of poorly water-soluble drugs [ 100 ]. Based on in vitro drug release studies, more than 90% of prednisolone was released within 2 min when the loaded MSN was incorporated into the formulation. This means a much faster, immediate release in comparison with formulations containing the free form of the drug. In addition, precise dosing can be accomplished utilizing nanocarriers for personalized medication; furthermore, enabling the production of low-dose preparations without content uniformity problems [ 100 ].
Silica Testing Methods: How to Test Purity, Particle Size, BET and Moisture
What is silica (SiO₂)?
What is the difference between fumed silica and precipitated silica?
silicon oxide anode 43. Tu B., Jonnalagadda S. Amorphous stabilization of BCS II drugs using mesoporous silica. Int. J. Pharm. 2024;663:124555. doi: 10.1016/j.ijpharm.2024.124555. [ DOI ] [ PubMed ] [ Google Scholar ]
What drives silica raw material prices?
silica supplier Europe This supports that the release rate depends on several components, among others, influenced by the pore size, the pore structure, the amount of drug loaded, the solubility of the API, and the resulting interaction between the carrier and the transported molecules [ 2 ]. By modifying these, the release kinetics can be controlled to a small extent, but a considerable influence can only be attained by surface functionalization of the mesopores. The following table contains some experimental data in terms of drug release in case of the previously shown APIs ( Table 2 ).
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.